Back to Search
Start Over
Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer.
- Source :
- Journal of Clinical Oncology; 8/1/2023, Vol. 41 Issue 22, p3851-3862, 12p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 41
- Issue :
- 22
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 167365242
- Full Text :
- https://doi.org/10.1200/JCO.22.01994